Idorsia (verify)
Idorsia (verify) is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Idorsia (verify) products.
Drugs from Idorsia (verify) supported via NPP
| Brand | Generic | Category | Indication |
|---|---|---|---|
| Hernexeos | daridorexant class | Neurology | Insomnia — OUT OF SCOPE (daridorexant class = DEA Schedule IV dual orexin receptor antagonist; PlatformCo does not handle controlled substances. Fatima's DEA-registered entity may pursue separately. Note: drug-name mapping 'Hernexeos' is uncertain — verify FDA label before any future action.) |
How NPP access to Idorsia (verify) products works
Reserve Meds sources Idorsia (verify) products from DSCSA-compliant US specialty wholesalers, not from parallel-import channels. All supply is US-FDA-provenance.
Not affiliated with Idorsia (verify)
Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Idorsia (verify).